_:nb632f3560b134748a62cd318108c60a1xb32
<http://schema.org/description>
"I am a PhD and Professor of Pharm Sci at a pharmacy school who teaches first year PharmD students about PGx in my Biochemistry course.  This year for the first time, I had all these students have their own PGx profiles analyzed.  I wanted my students to see how PGx is the foundation of the future of pharmacy.  \r\n\r\nI took the PGx in Practice course after reading Dr. McCarthy's excellent white paper on how 23&amp;Me testing suffers from false positives for most PGx genes.  My own profile from 23&amp;Me for Cyp2D6 was called *1/*1, a normal metaboliser, apparently by default.  However, sequence-based analysis by UNC-Chapel Hill showed that I am actually *4B/*41 and a poor metaboliser.  So the limitations of testing results are a personal topic that I now emphasize to my students.  \r\n\r\nI enjoyed the course because I have little experience with the realities of clinical aspects.  This is the third course in PGx that I have taken.  It is the most condensed, and I appreciated that there is no time wasted.  The overall coverage of the topics is well-paced and does not overlap with the other courses with worthwhile additions and information.  The ability to download the resources is also a benefit.  There is a consistent focus on the application of PGx to patients, rather than over-stating the basics of DNA and polymorphisms and alleles.  Therefore, with my background, this was an excellent training.  For those who aren't already inundated with molecular biology, this course might not be as useful.  But with the emphasis on how to select the drugs of interest for PGx, how to find testing, how to compare reports, and how to approach patients, the PGx in Practice course is exceedingly useful.  I look forward to continuing to follow the PMA website as topics continue to evolve and expand.  "
<https://precision-medicine-academy.thinkific.com/courses/pgx-in-practice>